Marcum Wealth LLC Sells 207 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Marcum Wealth LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.5% in the 1st quarter, HoldingsChannel.com reports. The fund owned 4,352 shares of the healthcare conglomerate’s stock after selling 207 shares during the quarter. Marcum Wealth LLC’s holdings in UnitedHealth Group were worth $2,279,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $28,000. Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group in the 4th quarter worth $30,000. Finally, Promus Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at about $32,000. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

UNH has been the subject of several recent analyst reports. Robert W. Baird decreased their target price on UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating for the company in a research note on Wednesday, May 14th. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a research report on Friday, May 16th. TD Securities reaffirmed a “hold” rating and set a $308.00 target price (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Oppenheimer decreased their price target on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 14th. Finally, Erste Group Bank cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 30th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $441.87.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $297.49 on Thursday. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a fifty day moving average price of $439.50 and a two-hundred day moving average price of $498.65. The firm has a market capitalization of $269.87 billion, a P/E ratio of 19.19, a P/E/G ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter last year, the firm earned $6.91 earnings per share. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the purchase, the director now owns 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John H. Noseworthy purchased 300 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the transaction, the director now owns 6,063 shares in the company, valued at $1,892,626.08. This represents a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders acquired 109,408 shares of company stock valued at $31,607,768 in the last three months. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.